Stock Events

Stock Events

Grace Therapeutics (GRCE) Q3 2025 Earnings

12AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.37

-0.21

-0.05

0.11

Details

Expected EPS

-0.22

Actual EPS

-0.21

Surprise EPS

0.01

Surprise Percent

+4.55%

Description

Grace Therapeutics (GRCE) has reported earnings of -0.21 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.